{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T05:50:21Z","timestamp":1792475421656,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.urolonc.2013.05.011","type":"journal-article","created":{"date-parts":[[2013,9,17]],"date-time":"2013-09-17T13:31:26Z","timestamp":1379424686000},"page":"524-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Cav1.3 channel \u03b11D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers"],"prefix":"10.1016","volume":"32","author":[{"given":"Ruibao","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruitao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaoti","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxing","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Tawfik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brantley Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urolonc.2013.05.011_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/biof.158","article-title":"Voltage-gated calcium channels and disease","volume":"37","author":"Cain","year":"2011","journal-title":"Biofactors"},{"key":"10.1016\/j.urolonc.2013.05.011_bib2","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1152\/physrev.00057.2009","article-title":"The ss subunit of voltage-gated Ca2+ channels","volume":"90","author":"Buraei","year":"2010","journal-title":"Physiol Rev"},{"key":"10.1016\/j.urolonc.2013.05.011_bib3","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nrc3105","article-title":"Calcium in tumour metastasis: new roles for known actors","volume":"11","author":"Prevarskaya","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2013.05.011_bib4","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2741\/4007","article-title":"Permeation and gating mechanisms in store-operated CRAC channels","volume":"17","author":"Engh","year":"2012","journal-title":"Front Biosci"},{"key":"10.1016\/j.urolonc.2013.05.011_bib5","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1054\/ceca.1999.0030","article-title":"Interplay between Ca2+ release and Ca2+ influx underlies localized hyperpolarization-induced [Ca2+]i waves in prostatic cells","volume":"25","author":"Perret","year":"1999","journal-title":"Cell Calcium"},{"key":"10.1016\/j.urolonc.2013.05.011_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<259::AID-IJC20>3.0.CO;2-4","article-title":"Effects of the calcium influx inhibitor carboxyamido-triazole on the proliferation and invasiveness of human prostate tumor cell lines","volume":"68","author":"Wasilenko","year":"1996","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2013.05.011_bib7","doi-asserted-by":"crossref","first-page":"47608","DOI":"10.1074\/jbc.M107011200","article-title":"Ca2+ pools and cell growth. Evidence for sarcoendoplasmic Ca2+-ATPases 2B involvement in human prostate cancer cell growth control","volume":"276","author":"Legrand","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2013.05.011_bib8","first-page":"2045","article-title":"Inhibition by anticonvulsants of prostate-specific antigen and interleukin-6 secretion by human prostate cancer cells","volume":"21","author":"Abdul","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib9","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0006-291X(91)91338-D","article-title":"Effects of androgen on intracellular calcium of LNCaP cells","volume":"179","author":"Steinsapir","year":"1991","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.urolonc.2013.05.011_bib10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1095\/biolreprod63.3.736","article-title":"Rapid androgen actions on calcium signaling in rat sertoli cells and two human prostatic cell lines: similar biphasic responses between 1 picomolar and 100 nanomolar concentrations","volume":"63","author":"Lyng","year":"2000","journal-title":"Biol Reprod"},{"key":"10.1016\/j.urolonc.2013.05.011_bib11","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/endo.136.5.7720667","article-title":"Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP","volume":"136","author":"Gong","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.urolonc.2013.05.011_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/pros.2990170302","article-title":"Role of calcium in the programmed death of rat prostatic glandular cells","volume":"17","author":"Martikainen","year":"1990","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.05.011_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/pros.2990130204","article-title":"Calcium channel antagonists delay regression of androgen-dependent tissues and suppress gene activity associated with cell death","volume":"13","author":"Connor","year":"1988","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.05.011_bib14","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1210\/en.2009-0991","article-title":"1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion","volume":"151","author":"Washington","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.urolonc.2013.05.011_bib15","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1161\/01.HYP.29.5.1091","article-title":"Cancer risk in users of calcium channel blockers","volume":"29","author":"Olsen","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.urolonc.2013.05.011_bib16","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004872-199816010-00017","article-title":"Cancer risk of hypertensive patients taking calcium antagonists","volume":"16","author":"Hole","year":"1998","journal-title":"J Hypertens"},{"key":"10.1016\/j.urolonc.2013.05.011_bib17","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S0895-7061(98)00176-9","article-title":"Calcium channel blocker use and the risk of prostate cancer","volume":"11","author":"Vezina","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.urolonc.2013.05.011_bib18","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1158\/1055-9965.EPI-03-0093","article-title":"Inverse association between prostate cancer and the use of calcium channel blockers","volume":"13","author":"Debes","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.urolonc.2013.05.011_bib19","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S1047-2797(01)00246-0","article-title":"Hypertension, heart rate, use of antihypertensives, and incident prostate cancer","volume":"11","author":"Fitzpatrick","year":"2001","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.urolonc.2013.05.011_bib20","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1158\/1535-7163.MCT-04-0313","article-title":"Small-interfering RNA-induced androgen receptor silencing leads to apoptotic cell death in prostate cancer","volume":"4","author":"Liao","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.urolonc.2013.05.011_bib21","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1038\/onc.2008.91","article-title":"Phosphoinositide 3-OH kinase p85alpha and p110beta are essential for androgen receptor transactivation and tumor progression in prostate cancers","volume":"27","author":"Zhu","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2013.05.011_bib22","doi-asserted-by":"crossref","first-page":"5944","DOI":"10.1523\/JNEUROSCI.21-16-05944.2001","article-title":"Neuronal Ca(V)1.3alpha(1) L-type channels activate at relatively hyperpolarized membrane potentials and are incompletely inhibited by dihydropyridines","volume":"21","author":"Xu","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.urolonc.2013.05.011_bib23","doi-asserted-by":"crossref","first-page":"10824","DOI":"10.1074\/jbc.M108754200","article-title":"Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells","volume":"277","author":"Mariot","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2013.05.011_bib24","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.urolonc.2013.05.011_bib25","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1206735","article-title":"Interleukin-4 enhances prostate-specific antigen expression by activation of the androgen receptor and Akt pathway","volume":"22","author":"Lee","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.urolonc.2013.05.011_bib26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/pros.21345","article-title":"G-protein alpha-s and -12 subunits are involved in androgen-stimulated PI3K activation and androgen receptor transactivation in prostate cancer cells","volume":"71","author":"Liu","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.05.011_bib27","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1016\/S0002-9440(10)62490-X","article-title":"Differential expression of interleukin-8 and its receptors in the neuroendocrine and non-neuroendocrine compartments of prostate cancer","volume":"166","author":"Huang","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.urolonc.2013.05.011_bib28","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/pros.20521","article-title":"Aberrant expression of SWI\/SNF catalytic subunits BRG1\/BRM is associated with tumor development and increased invasiveness in prostate cancers","volume":"67","author":"Sun","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.urolonc.2013.05.011_bib29","first-page":"5974","article-title":"Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer","volume":"61","author":"Welsh","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib30","first-page":"5692","article-title":"Expression profiling reveals hepsin overexpression in prostate cancer","volume":"61","author":"Magee","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib31","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/mc.10018","article-title":"Gene expression analysis of prostate cancers","volume":"33","author":"Luo","year":"2002","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.urolonc.2013.05.011_bib32","first-page":"4499","article-title":"Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease","volume":"62","author":"LaTulippe","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib33","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1535-6108(02)00030-2","article-title":"Gene expression correlates of clinical prostate cancer behavior","volume":"1","author":"Singh","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2013.05.011_bib34","first-page":"3877","article-title":"Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression","volume":"63","author":"Vanaja","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib35","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1073\/pnas.0304146101","article-title":"Gene expression profiling identifies clinically relevant subtypes of prostate cancer","volume":"101","author":"Lapointe","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2013.05.011_bib36","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1200\/JCO.2004.05.158","article-title":"Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy","volume":"22","author":"Yu","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2013.05.011_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ccr.2005.10.001","article-title":"Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression","volume":"8","author":"Varambally","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2013.05.011_bib38","doi-asserted-by":"crossref","first-page":"4011","DOI":"10.1158\/0008-5472.CAN-05-3055","article-title":"Sex-determining region Y box 4 is a transforming oncogene in human prostate cancer cells","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.urolonc.2013.05.011_bib40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1158\/0008-5472.CAN-07-2608","article-title":"Tumor immunobiological differences in prostate cancer between African-American and European-American men","volume":"68","author":"Wallace","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib41","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1158\/1078-0432.CCR-09-0911","article-title":"Identification of the transcription factor single-minded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer","volume":"15","author":"Arredouani","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ccr.2010.05.026","article-title":"Integrative genomic profiling of human prostate cancer","volume":"18","author":"Taylor","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.urolonc.2013.05.011_bib43","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature11125","article-title":"The mutational landscape of lethal castration-resistant prostate cancer","volume":"487","author":"Grasso","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2013.05.011_bib44","doi-asserted-by":"crossref","first-page":"8253","DOI":"10.1200\/JCO.2005.03.4777","article-title":"Biology of progressive, castration-resistant prostate cancer: directed therapies targeting the androgen-receptor signaling axis","volume":"23","author":"Scher","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urolonc.2013.05.011_bib45","first-page":"4180","article-title":"Prostate-localized and androgen-regulated expression of the membrane-bound serine protease TMPRSS2","volume":"59","author":"Lin","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib46","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrc2402","article-title":"Recurrent gene fusions in prostate cancer","volume":"8","author":"Kumar-Sinha","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.urolonc.2013.05.011_bib47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1593\/neo.07822","article-title":"Role of the TMPRSS2-ERG gene fusion in prostate cancer","volume":"10","author":"Tomlins","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.urolonc.2013.05.011_bib48","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1073\/pnas.0711711105","article-title":"A causal role for ERG in neoplastic transformation of prostate epithelium","volume":"105","author":"Klezovitch","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.urolonc.2013.05.011_bib49","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1038\/nature07738","article-title":"ETS rearrangements and prostate cancer initiation","volume":"457","author":"Carver","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2013.05.011_bib50","doi-asserted-by":"crossref","first-page":"8516","DOI":"10.1158\/0008-5472.CAN-08-1147","article-title":"Pleiotropic biological activities of alternatively spliced TMPRSS2\/ERG fusion gene transcripts","volume":"68","author":"Wang","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib51","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1093\/jnci\/djn150","article-title":"Estrogen-dependent signaling in a molecularly distinct subclass of aggressive prostate cancer","volume":"100","author":"Setlur","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urolonc.2013.05.011_bib52","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1464-410X.2008.08200.x","article-title":"Integration of ERG gene mapping and gene-expression profiling identifies distinct categories of human prostate cancer","volume":"103","author":"Jhavar","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.urolonc.2013.05.011_bib53","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1593\/neo.12600","article-title":"Molecular subtyping of primary prostate cancer reveals specific and shared target genes of different ETS rearrangements","volume":"14","author":"Paulo","year":"2012","journal-title":"Neoplasia"},{"key":"10.1016\/j.urolonc.2013.05.011_bib54","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2164\/jandrol.106.000554","article-title":"Androgens induce increases in intracellular calcium via a G protein-coupled receptor in LNCaP prostate cancer cells","volume":"27","author":"Sun","year":"2006","journal-title":"J Androl"},{"key":"10.1016\/j.urolonc.2013.05.011_bib55","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1016\/S0021-9258(17)34550-7","article-title":"Characterization of ionomycin as a calcium ionophore","volume":"253","author":"Liu","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2013.05.011_bib56","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/ijc.24778","article-title":"Adeno-associated virus-delivered short hairpin-structured RNA for androgen receptor gene silencing induces tumor eradication of prostate cancer xenografts in nude mice: a preclinical study","volume":"126","author":"Sun","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urolonc.2013.05.011_bib57","doi-asserted-by":"crossref","first-page":"401","DOI":"10.2174\/1389450111314040002","article-title":"Androgen receptor: past, present and future","volume":"14","author":"Schmidt","year":"2013","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.urolonc.2013.05.011_bib58","first-page":"370","article-title":"Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells","volume":"9","author":"Lee","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urolonc.2013.05.011_bib59","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1046\/j.1471-4159.1997.69020845.x","article-title":"Mechanisms of inhibition of calmodulin-stimulated cyclic nucleotide phosphodiesterase by dihydropyridine calcium antagonists","volume":"69","author":"Sharma","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.urolonc.2013.05.011_bib60","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0006-2952(89)90332-8","article-title":"Activation of protein kinase C by the dihydropyridine calcium channel blocker, felodipine","volume":"38","author":"Sutherland","year":"1989","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.urolonc.2013.05.011_bib61","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/0006-2952(85)90432-0","article-title":"Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase","volume":"34","author":"Lamers","year":"1985","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.urolonc.2013.05.011_bib62","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/292777a0","article-title":"Interaction of the antihypertensive drug felodipine with calmodulin","volume":"292","author":"Bostrom","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.urolonc.2013.05.011_bib63","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1056\/NEJMoa1207506","article-title":"Increased survival with enzalutamide in prostate cancer after chemotherapy","volume":"367","author":"Scher","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2013.05.011_bib64","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMoa1209096","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","volume":"368","author":"Ryan","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.urolonc.2013.05.011_bib65","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.tips.2011.02.012","article-title":"Structural and functional differences between L-type calcium channels: crucial issues for future selective targeting","volume":"32","author":"Zuccotti","year":"2011","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.urolonc.2013.05.011_bib66","doi-asserted-by":"crossref","first-page":"19566","DOI":"10.1074\/jbc.M401481200","article-title":"Non-voltage-gated L-type Ca2+ channels in human T cells: pharmacology and molecular characterization of the major alpha pore-forming and auxiliary beta-subunits","volume":"279","author":"Stokes","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.urolonc.2013.05.011_bib67","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.1210\/en.2002-0164","article-title":"Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells","volume":"144","author":"Estrada","year":"2003","journal-title":"Endocrinology"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143913002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:02:31Z","timestamp":1761040951000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143913002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S1078143913002433"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.05.011","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cav1.3 channel \u03b11D protein is overexpressed and modulates androgen receptor transactivation in prostate cancers","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2013.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}